开发和验证一种基于炎症的诺姆图谱,用于预测末期病患者的动脉静脉囊成熟失败
Bin Zhao1, Gang Fu1, Shen Zhan1
1Department of Nephrology, Beijing Haidian Hospital (Haidian Section of Pecking University Third Hospital), Beijing, 100080, China.
Langenbeck's archives of surgery
|July 28, 2025
概括
动脉静脉 (AVF) 的成熟与炎症标志物有关. 高系统炎症反应指数 (SIRI),三糖-葡萄糖指数与体重指数 (TyG-BMI) 结合,以及高灵敏度C反应蛋白与白蛋白比率 (HRR) 预测血液透析患者的AVF失败.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 血管外科 血管外科
- 生物标志物研究 生物标志物研究
背景情况:
- 动脉静脉 (AVF) 是末期病 (ESRD) 患者血液透析的首选血管接入方式.
- 影响AVF成熟的因素,特别是炎症标志物,需要进一步调查.
研究的目的:
- 调查系统性炎症反应指数 (SIRI),甘油三糖指数与体重指数 (TyG-BMI) 结合,以及高灵敏度C反应蛋白与白蛋白比率 (HRR) 与AVF成熟之间的关联.
- 开发和验证AVF成熟失败的预测模型.
主要方法:
- 分析了249名ESRD患者的队列,这些患者首次接受AVF创建.
- 评估了手术前的临床和实验室数据,包括SIRI,TyG-BMI和HRR.
- 限制性立方线模型,多变量考克斯回归和预测性名谱被用于识别AVF成熟失败的预测因素.
主要成果:
- 这项研究包括249名患者,AVF成熟率为73.5%.
- SIRI,TyG-BMI和HRR与AVF成熟线性相关.
- 确定SIRI (HR=1.69),TyG-BMI (HR=2.68) 和HRR (HR=1.44) 作为AVF未成熟的独立预测因素.
结论:
- 非成熟的AVF独立地与SIRI,TyG-BMI和HRR的升高有关.
- 结合这些基于炎症的生物标志物的诺莫图显示出高预测准确度,用于识别高风险患者.
- 这种名图可以帮助早期识别和管理患有AVF成熟失败风险的患者.
相关概念视频
Hemodialysis I: Introduction
301
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
301
Acute Kidney Injury IV: Diagnostic Studies and Prevention
57
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
57


